Mikael Dolsten, M.D., Ph.D., Joins TRIO Pharmaceuticals as Chairman

Core Viewpoint - Mikael Dolsten, M.D., Ph.D., has been appointed as the Chairman of TRIO Pharmaceuticals, indicating a strategic leadership change within the company [1] Company Summary - The appointment of Mikael Dolsten is expected to bring significant expertise to TRIO Pharmaceuticals, potentially enhancing its strategic direction and operational effectiveness [1]